HOB Biotech Group (SHSE:688656) FCF Margin % : -84.63% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HOB Biotech Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HOB Biotech Group's Free Cash Flow for the three months ended in Mar. 2024 was ¥-72.4 Mil. HOB Biotech Group's Revenue for the three months ended in Mar. 2024 was ¥85.6 Mil. Therefore, HOB Biotech Group's FCF Margin % for the quarter that ended in Mar. 2024 was -84.63%.

As of today, HOB Biotech Group's current FCF Yield % is -6.72%.

The historical rank and industry rank for HOB Biotech Group's FCF Margin % or its related term are showing as below:

SHSE:688656' s FCF Margin % Range Over the Past 10 Years
Min: -50.53 Med: -4.54 Max: 13.03
Current: -24.56

During the past 8 years, the highest FCF Margin % of HOB Biotech Group was 13.03%. The lowest was -50.53%. And the median was -4.54%.

SHSE:688656's FCF Margin % is ranked worse than
62.41% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -7.11 vs SHSE:688656: -24.56

HOB Biotech Group FCF Margin % Historical Data

The historical data trend for HOB Biotech Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HOB Biotech Group FCF Margin % Chart

HOB Biotech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

13.03

0.55

-19.86

-50.53

-19.10

HOB Biotech Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-61.57	8.14	-11.38	-23.41	-84.63

Competitive Comparison of HOB Biotech Group's FCF Margin %

For the Medical Devices subindustry, HOB Biotech Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HOB Biotech Group's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HOB Biotech Group's FCF Margin % falls into.

HOB Biotech Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HOB Biotech Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-75.338	/	394.406
	=	-19.10 %

HOB Biotech Group's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-72.441	/	85.6
	=	-84.63 %

HOB Biotech Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of HOB Biotech Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

HOB Biotech Group (SHSE:688656) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HOB Biotech Group Corp Ltd (SHSE:688656) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 218 Xinghu Road, Suzhou Industrial Park, C10 Building, Jiangsu, Suzhou, CHN, 215123

Website

http://www.hob-biotech.com

HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.

HOB Biotech Group (SHSE:688656) Headlines

No Headlines